Managing disruptive behaviour in autism-spectrum disorder with guanfacine
- PMID: 30125242
- PMCID: PMC6158025
- DOI: 10.1503/jpn.180039
Managing disruptive behaviour in autism-spectrum disorder with guanfacine
Conflict of interest statement
References
-
- Kanne SM, Mazurek MO. Aggression in children and adolescents with ASD: prevalence and risk factors. J Autism Dev Disord. 2011;41:926–37. - PubMed
-
- McDougle CJ, Scahill L, Aman MG, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005;162:1142–8. - PubMed
-
- Marcus RN, Owen R, Kamen L, et al. A double-blind, randomized, placebo-controlled study of fixed-dose aripiprazole in children and adolescents with autistic disorder. J Am Acad Child Adolesc Psychiatry. 2009;48:1110–9. - PubMed
-
- Owen R, Sikich L, Marcus RN, et al. Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics. 2009;124:1533–40. - PubMed
